# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Medpace Hldgs (NASDAQ:MEDP) raises FY2025 GAAP EPS guidance from $13.76-$14.53 to $14.60-$14.86 vs $14.07 analyst estimate. Rai...
Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $3.86 per share which beat the analyst consensus estimate of $3.52 b...
Mizuho analyst Ann Hynes maintains Medpace Hldgs (NASDAQ:MEDP) with a Outperform and raises the price target from $510 to $575.
Barclays analyst Luke Sergott downgrades Medpace Hldgs (NASDAQ:MEDP) from Equal-Weight to Underweight and lowers the price t...